title: [Socio-economic impact of allergic rhinitis and perspectives of appropriate therapy].
abstract: Allergic rhinitis is a very common disease that causes high economic costs. Furthermore inadequate treatment can lead to bronchial asthma. Against this background, drugs for the treatment of allergic rhinitis should be evaluated from a comprehensive medical-economic perspective. The new combination of an antihistamine and a corticosteroid, introduced in the market in 2013, emerges as useful pharmaceutical alternative, both with regard to the medical outcome parameters as well as cost-effectiveness.
authors.forename: Uwe
authors.initials: U
authors.lastname: May
mesh_terms: D000041:Absenteeism; D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D000730:Androstadienes / Q000008:administration & dosage* / Q000191:economics*; D001249:Asthma / Q000188:drug therapy / Q000191:economics; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis / Q000191:economics; D004338:Drug Combinations; D005260:Female; D000068298:Fluticasone; D005858:Germany; D006801:Humans; D008297:Male; D009313:National Health Programs / Q000191:economics*; D010793:Phthalazines / Q000008:administration & dosage* / Q000191:economics*; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy* / Q000191:economics*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy* / Q000191:economics*; D012959:Socioeconomic Factors
chemical_list: D000730:Androstadienes; D004338:Drug Combinations; D010793:Phthalazines; D000068298:Fluticasone; C020976:azelastine